Skip to main content

Evotec initiates ‘Campus Curie’ in Toulouse

Drug discovery firm Evotec, which also owns the CDMO Aptuit, has acquired the ‘Biopark by Sanofi’ (BBS) operation in Toulouse, France, and will rename it ‘Campus Curie’. The 19 employees are all transferring. Financial terms were not disclosed.

The company said that this acquisition will allow it “to significantly expand its existing capacities at the site over the near to mid-term while retaining maximum flexibility to build up long-term capacity as needed”.

Sanofi to establish API player

Big Pharma giant Sanofi has announced plans to create a stand-alone company dedicated to the production and marketing of APIs to third parties.
Subscribe to Sanofi

 

 

 

AMRI banner advert